Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.

Archives of neurology - 1 Jun 2005

Devanand D P, Pelton Gregory H, Zamora Diana, Liu Xinhua, Tabert Matthias H, Goodkind Madeleine, Scarmeas Nikolaos, Braun Ilana, Stern Yaakov, Mayeux Richard

Abstract excerpt

BACKGROUND: In cognitively impaired patients without dementia, the utility of apolipoprotein E (APOE) genotyping is unclear. OBJECTIVE: To evaluate the predictive utility of the APOE epsilon4 genotype for conversion to probable Alzheimer disease (AD). DESIGN: Naturalistic, longitudinal study. SETTING: Memory disorders outpatient clinic. PATIENTS: A total of 136 patients with memory complaints were determined to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease
Share to Ambulatory Care

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Apolipoprotein E4

Share to Apolipoproteins E

Share to Cognition Disorders

Share to Follow-Up Studies

Share to Longitudinal Studies

Share to Predictive Value of Tests

Source

Identifiers

PMID: 15956169
DOI: 10.1001/archneur.62.6.975

Genes

APOE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.PMID 15956169Read ↗

Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals.Semantic proximity Read ↗

Predictive value of APOE genotyping in incipient Alzheimer's disease.Semantic proximity Read ↗

Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study.Semantic proximity Read ↗

The apolipoprotein E genotype predicts longitudinal transitions to mild cognitive impairment but not to Alzheimer's dementia: findings from a nationally representative study.Semantic proximity Read ↗

Impact of APOE in mild cognitive impairment.Semantic proximity Read ↗

Apolipoprotein E4 is only a weak predictor of dementia and cognitive decline in the general population.Semantic proximity Read ↗

The utility of apolipoprotein E genotyping in the diagnosis of Alzheimer disease in a community-based case series.Semantic proximity Read ↗

Apolipoprotein E genotype and rate of decline in probable Alzheimer's disease.Semantic proximity Read ↗

APOE genotype in the diagnosis of Alzheimer's disease in patients with cognitive impairment.Semantic proximity Read ↗

The APOE epsilon4 allele is associated with incident mild cognitive impairment among community-dwelling older persons.Semantic proximity Read ↗

Predictive value of APOE-ε4 allele for progression from MCI to AD-type dementia: a meta-analysis.Semantic proximity Read ↗

Apolipoprotein E genotype in the prediction of cognitive decline and dementia in a prospectively studied elderly population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.